Inventor
Brett Granger
Inventor
Sudbury, MA, US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
C07JSteroids12%
Y02ATechnologies for adaptation to climate change5%
Y02PClimate change mitigation technologies in the production or processing of goods5%
C07CAcyclic or carbocyclic compounds2%
PatentTitleYear
11,040,998Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof202111,008,304Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof202110,988,458Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof202110,968,199Cycloalkyl-containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof202110,961,272Process for preparation of sulfonyl carbamate bile acid derivatives202110,683,289Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof202010,683,279Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof202010,676,500Process for preparation of sulfonyl carbamate bile acid derivatives202010,597,382Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof202010,472,386Bile acid derivatives as FXR agonists and methods of use thereof201910,457,703Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof201910,450,301Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof201910,253,018Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof201910,246,439Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof201910,149,835Isoxazole derivatives as FXR agonists and methods of use thereof201810,144,729Isoxazole analogs as FXR agonists and methods of use thereof201810,138,228Isoxazole derivatives as FXR agonists and methods of use therof201810,080,741Isoxazole derivatives as FXR agonists and methods of use thereof201810,080,743Isoxazole derivatives as FXR agonists and methods of use thereof201810,080,742Isoxazole derivatives as FXR agonists and methods of use thereof2018Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2018–2021Patents assigned to ENANTA PHARM INC (20)· patent assignee history
2018Patents assigned to ELMORE PATENT LAW GROUP P C (1)· patent assignee history
2018–2021Based in Sudbury, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ENANTA PHARM INC | 20 | 2018–2021 |
| ELMORE PATENT LAW GROUP P C | 1 | 2018 |
Locations
| Location | Patents | Span |
|---|---|---|
| Sudbury, Massachusetts, US | 20 | 2018–2021 |